MEDICINE

Dermasoft

2% w/w Ointment · Mupirocin

Indications

Dermasoft ointment is indicated for the topical treatment of impetigo (skin diseases) due to Staphylococcus Aureus and Streptococcus Pyogenes. It is also indicated in folliculitis, furunculosis.

Pharmacology

Mupirocin is a naturally occurring antibiotic. It is an antibacterial agent produced by fermentation using the organism Pseudomonas fluorescens. It is active against a wide range of bacteria those responsible for the majority of skin infections, e.g. Staphylococcus aureus including methicillin-resistant Staphylococcus aureus (MRSA) other staphylococci and streptococci. It is also active against certain gram-negative pathogens, like Escherichia coli and Haemophilus influenzae. Mupirocin inhibits bacterial protein synthesis by reversibly and specially binding to bacterial isoleucyl transfer-RNA synthetase. Due to this unique mode of action, Mupirocin demonstrates no in vitro cross-resistance with other classes of antimicrobial agents. Mupirocin is bactericidal at concentrations achieved by topical administration. However, the minimum bactericidal concentration (MBC) against relevant pathogens is generally eight-fold to thirty-fold higher than the minimum inhibitory concentration (MIC). Mupirocin is a naturally occurring antibiotic. This antibacterial agent is produced by fermentation using the organism Pseudomonas fluorescens. It is active against a wide range of bacteria (e.g. Staphylococcus aureus including methicillin-resistant strains and Streptococcus pyogenes) those responsible for the majority of skin infections. It is also active against gram-negative pathogens, such as Escherichia coli and Haemophilus influenzae. Mupirocin inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl transfer-RNA synthetase.

Dosage and administration

A small amount of Bactropen ointment should be applied to the affected area 3 times daily for up to 10 days. The safety and effectiveness of Mupirocin ointment have been established in the age range of 2 months to 16 years. Pediatric Use: The safety and effectiveness of Mupirocin have been established in the age range of 2 months to 16 years. Use of the ointment in these age groups is supported by evidence from adequate and well-controlled studies of Mupirocin in impetigo in pediatric patients.

Interactions

No drug interaction has been identified with Dermasoft ointment.

Contraindications

The drug is contraindicated in individuals with a history of hypersensitivity reactions to Mupirocin or any of the components of the preparation.

Side effects

Reported side effects are burning, stinging or pain, itching and some patient may be suffered rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis and increased exudate.

Pregnancy and lactation

Reproduction studies on Mupirocin ointment in animals have revealed no evidence of harm to the foetus. As there is no clinical experience on it’s use during pregnancy, Mupirocin ointment should only be used in pregnancy when the potential benefits outweigh the possible risks of treatment. It is unknown whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Mupirocin ointment is administered to a nursing woman.

Precautions and warnings

Dermasoft ointment is not for ophthalmic or intra-nasal use. As with other antibacterial products, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. When Dermasoft is used on the face care should be taken to avoid the eyes. This is not suitable in conjunction with cannulae and at the site of central venous cannulation. In the event of a sensitization or severe local irritation from Dermasoft ointment, usage should be discontinued and appropriate alternative therapy for the infection instituted. Mixing of Dermasoft ointment with other preparations causes risk of dilution, resulting in a reduction of the antibacterial activity and potential loss of stability of the Dermasoft in the ointment.

Overdose

There is currently limited data with overdose of Dermasoft ointment. In the event of overdose, the patient should be treated supportively with appropriate monitoring as necessary.

Storage

Keep below 25° C temperature, protected from light and moisture. Do not keep in freeze. Keep out of the reach of children.

Similar brands of Mupirocin

Brands of Mupirocin
#BrandCompanyFormStrengthPrice
1DermaskinZenith Pharmaceuticals Ltd.Ointment2% w/wNot listed
2BactoverBeacon Pharmaceuticals PLCOintment2% w/wNot listed
3BactrobexBeximco Pharmaceuticals Ltd.Ointment2% w/wNot listed
4MupiskinEuro Pharma Ltd.Ointment2% w/wNot listed
5MupitopRenata PLCOintment2% w/wNot listed
6MupicinOrion Pharma Ltd.Ointment2% w/wNot listed
7BactribenDBL Pharmaceuticals Ltd.Cream2% w/wNot listed
8TopkillAd-din Pharmaceuticals Ltd.Ointment2% w/wNot listed
9BacronBiopharma LimitedOintment2% w/wNot listed
10BactodermUniMed UniHealth Pharmaceuticals Ltd.Ointment2% w/wNot listed
11BactrocinSquare Pharmaceuticals PLCOintment2% w/wNot listed
12DermobanOpsonin Pharma Ltd.Ointment2% w/wNot listed
13DermupinACME Laboratories Ltd.Ointment2% w/wNot listed
14MupiAlco Pharma Ltd.Ointment2% w/wNot listed
15MupibacPharmasia LimitedOintment2% w/wNot listed
16MupidermHealthcare Pharmaceuticals Ltd.Ointment2% w/wNot listed
17MupironEskayef Pharmaceuticals Ltd.Ointment2% w/wNot listed
18MurodermGeneral Pharmaceuticals Ltd.Ointment2% w/wNot listed
19MuronDrug International Ltd.Ointment2% w/wNot listed
20SystopACI LimitedOintment2% w/wNot listed
21TregoIncepta Pharmaceuticals Ltd.Ointment2% w/wNot listed
22SinabanThe IBN SINA Pharmaceutical PLCOintment2% w/wNot listed
23PirocinMedicon Pharmaceuticals Ltd.Ointment2% w/wNot listed
24MupitasKumudini Pharma Ltd.Ointment2% w/wNot listed
25PirobanNavana Pharmaceuticals Ltd.Ointment2% w/wNot listed
26BactropenNIPRO JMI Pharma Ltd.Ointment2% w/wNot listed
27MudermGlobe Pharmaceuticals Ltd.Ointment2% w/wNot listed
28TregoIncepta Pharmaceuticals Ltd.Nasal Ointment2% w/wNot listed
29TigocinPacific Pharmaceuticals Ltd.Ointment2% w/wNot listed
30DermocinAristopharma Ltd.Ointment2% w/wNot listed
See every brand of Mupirocin →

Common questions

What is Dermasoft used for?

Dermasoft ointment is indicated for the topical treatment of impetigo (skin diseases) due to Staphylococcus Aureus and Streptococcus Pyogenes. It is also indicated in folliculitis, furunculosis.

What is the generic name of Dermasoft?

Dermasoft contains Mupirocin, which belongs to the group: Topical Antibiotic preparations.

Who makes Dermasoft?

Dermasoft is marketed in Bangladesh by Team Pharmaceuticals Ltd..

How is Dermasoft taken?

A small amount of Bactropen ointment should be applied to the affected area 3 times daily for up to 10 days. The safety and effectiveness of Mupirocin ointment have been established in the age range of 2 months to 16 years. Always follow your doctor's instructions.

What are the side effects of Dermasoft?

Reported side effects are burning, stinging or pain, itching and some patient may be suffered rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis and increased exudate.

Is Dermasoft safe in pregnancy?

Reproduction studies on Mupirocin ointment in animals have revealed no evidence of harm to the foetus. As there is no clinical experience on it’s use during pregnancy, Mupirocin ointment should only be used in pregnancy when the potential benefits outweigh the possible risks of treatment. Ask your doctor before using it while pregnant or breastfeeding.

This page is general information and is not medical advice. It does not replace a registered doctor, and it is not a prescription or a recommendation to use any medicine or test. Prices are listed prices and may change. Always follow the advice of your doctor or pharmacist.